论文部分内容阅读
Nanomedicine options for colon cancer therapy have been limited by the lack of suitable carriers capable of delivering sufficient drug into tumors to cause lethal toxicity(1,2).To circumvent this limitation,we fabricated a camptothecin(CPT)-loaded poly(lactic-co-glycolic acid)nanoparticle(NP)with dual-surface functionalization—Pluronic F127 and chitosan—for inhibiting multi-drug resistant gene 1(MDR1)expression and enhancing tumor uptake.The resultant spherical NPs-P/C had a desirable particle size(~268 nm),slightly positive zeta-potential,and the ability to efficiently down-regulate the expression of MDR1.